Showing results (131-140 of 157) with videos related to
Sort By:
Pageof 16
NPJ Breast Cancer|February 4, 2021
Circulating tumor DNA dynamics in advanced breast cancer treated with CDK4/6 inhibition and endocrine therapyOlga Martínez-Sáez, Tomás Pascual, Fara Brasó-Maristany, et al.Scientific Data|April 14, 2023
A comprehensive dataset of annotated brain metastasis MR images with clinical and radiomic dataBeatriz Ocaña-Tienda, Julián Pérez-Beteta, José D Villanueva-García, et al.Revista Brasileira De Enfermagem|April 1, 2024
Access of people with pulmonary tuberculosis to government programs: Primary Care professionals' perceptionsHildegard Soares Barrozo de Lima, Vitória Regina Domingues Sodré, Cleide Aparecida Alves Souza, et al.Revista Brasileira De Enfermagem|April 27, 2022
Access to government social programs and the tuberculosis control program: a multicenter studyRegina Célia Gollner Zeitoune, Juliana Roza Dias, Flaviana Pereira Bastos Nascimento, et al.Nature Communications|January 22, 2020
Phenotypic changes of HER2-positive breast cancer during and after dual HER2 blockadeFara Brasó-Maristany, Gaia Griguolo, Tomás Pascual, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 8, 2024
A Preoperative Window-of-Opportunity Study of Oral SERD, Imlunestrant, in Newly Diagnosed ER-Positive, HER2-Negative Early Breast Cancer: Results from the EMBER-2 StudyPatrick Neven, Nicole Stahl, Maria Vidal, et al.Plos Neglected Tropical Diseases|March 15, 2019
Serological proteomic screening and evaluation of a recombinant egg antigen for the diagnosis of low-intensity Schistosoma mansoni infections in endemic area in BrazilVanessa Silva-Moraes, Lisa Marie Shollenberger, William Castro-Borges, et al.Nature Medicine|October 8, 2025
Trastuzumab deruxtecan in HER2-low metastatic breast cancer: long-term survival analysis of the randomized, phase 3 DESTINY-Breast04 trialShanu Modi, William Jacot, Hiroji Iwata, et al.Journal of the National Cancer Institute|December 28, 2022
HER2DX ERBB2 mRNA expression in advanced HER2-positive breast cancer treated with T-DM1Fara Brasó-Maristany, Gaia Griguolo, Nuria Chic, et al.NPJ Breast Cancer|January 5, 2021
Clinical, pathological, and PAM50 gene expression features of HER2-low breast cancerFrancesco Schettini, Nuria Chic, Fara Brasó-Maristany, et al.Pageof 16